Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M17.8Revenue $M46.9Net Margin (%)0Z-Score-0.9
Enterprise Value $M2.5EPS $-0.5Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book1.210-y EBITDA Growth Rate %-49.7Quick Ratio11.2Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-45.3Current Ratio11.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-51.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-54.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M21.2ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with ABIO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABIOJean-Marie Eveillard 2010-03-31 Sold Out -0.01%$2.64 - $8.22
($3.15)
$ 0.84-275%Sold Out0
ABIOJean-Marie Eveillard 2009-12-31 Reduce$2.25 - $4.32
($3.01)
$ 0.84-258%Reduce -27.96%412,321
ABIOJean-Marie Eveillard 2009-09-30 Add0.01%$2.28 - $4.4
($3.48)
$ 0.84-314%Add 62.38%572,321
ABIOJean-Marie Eveillard 2009-06-30 Sold Out -0.02%$2.58 - $13.45
($6.95)
$ 0.84-727%Sold Out0
ABIOJean-Marie Eveillard 2009-03-31 Buy 0.02%$3.99 - $6.4
($5.2)
$ 0.84-519%New holding283,453
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABIO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ABIO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Selby Brian L.VP, Finance 2015-03-02Sell1,125$0.7118.31 view
BRISTOW MICHAEL RSee Remarks 2015-03-02Sell5,446$0.7118.31 view
mccormack riley10% Owner 2015-01-16Sell350,000$0.7610.53 view
mccormack riley10% Owner 2015-01-07Sell550,000$0.92-8.7 view
BRISTOW MICHAEL RPresident and CEO 2014-09-18Sell13,853$1.3-35.38 view
Wheeler Patrick MCFO 2014-09-18Sell8,246$1.31-35.88 view
mccormack riley10% Owner 2014-02-04Buy1,000,000$1.7-50.59 view
mccormack riley10% Owner 2013-09-27Sell0$0-50.59 view
Atlas Venture Fund VII L P10% Owner 2012-10-25Sell0$0-50.59 view
Grais Linda SDirector 2010-03-29Sell210,809$7.38-88.62 view

Press Releases about ABIO :

    Quarterly/Annual Reports about ABIO:

    News about ABIO:

    Articles On GuruFocus.com
    comment on ABIO Mar 15 2013 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Nov 15 2010 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Aug 10 2010 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) May 10 2010 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Nov 16 2009 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Aug 10 2009 
    ARCA biopharma Inc. Reports Operating Results (10-Q) May 15 2009 
    ARCA biopharma Inc. Reports Operating Results (10-Q) Feb 07 2009 

    More From Other Websites
    10-K for ARCA biopharma, Inc. May 02 2015
    ARCA biopharma Gains on Fast Track Status for Gencaro - Analyst Blog Apr 14 2015
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 13 2015
    ARCA biopharma (ABIO) Stock Surges Today on FDA Fast Track Designation Apr 13 2015
    ARCA biopharma Receives FDA Fast Track Designation for Gencaro™ Atrial Fibrillation Development in... Apr 13 2015
    ARCA BIOPHARMA, INC. Financials Mar 26 2015
    ARCA biopharma Provides GENETIC-AF Clinical Trial Update Mar 20 2015
    ARCA BIOPHARMA, INC. Files SEC form 10-K, Annual Report Mar 19 2015
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 16 2015
    ARCA biopharma Provides GENETIC-AF Clinical Trial Update Mar 16 2015
    3 Biotech stocks Under $10 to Trade for Breakouts Mar 05 2015
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Feb 23 2015
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers Feb 17 2015
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 04 2015
    ARCA biopharma Announces Patent Issuance for Methods and Compositions of S-isomer Formulation of... Feb 04 2015
    ARCA BIOPHARMA, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial... Dec 30 2014
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 11 2014
    Arca biopharma Announces Activation of First Canadian Genetic-AF Clinical Trial Site Dec 11 2014
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 10 2014
    ARCA biopharma Receives FDA Orphan Drug Designation for rNAPc2 as a Potential Treatment for Ebola Dec 10 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK